Recordati Industria Chimica e Farmaceutica Logo

Recordati Industria Chimica e Farmaceutica

Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.

REC | XMIL

Overview

Corporate Details

ISIN(s):
IT0003828271 (+4 more)
LEI:
815600FBF92FD3531704
Country:
Italy
Address:
VIA MATTEO CIVITALI, 1, 20148 MILANO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Recordati Industria Chimica e Farmaceutica is an international pharmaceutical group dedicated to the research, development, manufacturing, and marketing of pharmaceuticals. With a history of nearly 100 years, the company develops and commercializes drugs for both common pathologies and rare diseases, operating in approximately 150 countries. Its business model integrates a chemicals division that produces and supplies Active Pharmaceutical Ingredients (APIs) to a global customer base alongside its core pharmaceutical operations. The group focuses on improving the health and quality of life for patients worldwide.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-08 20:07
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 734.0 KB
2025-10-08 20:05
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 231.5 KB
2025-10-07 20:07
Director's Dealing
Allegato 3F
Italian 30.0 KB
2025-10-01 20:08
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 770.3 KB
2025-10-01 20:07
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
English 1016.9 KB
2025-09-23 20:05
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 611.2 KB
2025-09-23 20:04
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
English 907.3 KB
2025-09-18 20:04
Board/Management Information
RECORDATI ANNOUNCES RESIGNATION OF LUIGI LA CORTE AS GROUP CFO WHILE MAINTAININ…
English 172.7 KB
2025-09-18 20:02
Board/Management Information
RECORDATI COMUNICA LE DIMISSIONI DI LUIGI LA CORTE DAL RUOLO DI GROUP CFO, MANT…
Italian 158.3 KB
2025-09-17 20:07
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 813.4 KB
2025-09-17 20:04
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 771.3 KB
2025-09-10 20:09
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 334.7 KB
2025-09-10 20:06
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
Italian 291.7 KB
2025-09-03 20:15
Director's Dealing
Allegato 3F
Italian 29.8 KB
2025-09-03 20:06
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
English 796.0 KB

Automate Your Workflow. Get a real-time feed of all Recordati Industria Chimica e Farmaceutica filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Recordati Industria Chimica e Farmaceutica via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
GENOLUTION INC. Logo
Develops molecular diagnostic and RNAi solutions for genetic testing and life sciences research.
South Korea 225220
Genome&Company Logo
Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.
South Korea 314130
Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.
South Korea 228760
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
GENOTECH CORP. Logo
A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.
South Korea 066830
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GI Innovation Inc. Logo
Develops fusion protein biologics for oncology, allergic, and metabolic diseases.
South Korea 358570
GlaxoSmithKline PLC Logo
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom GSK
GL Pharm Tech Corp. Logo
Develops improved drugs and generics, and licenses proprietary drug formulation technologies.
South Korea 204840
GNI  Group Ltd. Logo
Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.
Japan 2160

Talk to a Data Expert

Have a question? We'll get back to you promptly.